In this video, Jia Ruan, MD, PhD, Weill Cornell Medicine, New York, NY, shares some insights into treatment approaches for older patients with mantle cell lymphoma (MCL), highlighting the value of chemotherapy-free regimens. Dr Ruan then goes on to discuss various Phase II and Phase III clinical trials evaluating these regimens, including ibrutinib in combination with rituximab, and zanubrutinib in combination with rituximab. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.